Items where authors include "Phillips, M"
Up a levelArticle
Schmid, P, Abraham, J, Chan, S et al. (26 more authors) (2020) Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial. Journal of Clinical Oncology, 38 (5). pp. 423-433. ISSN 0732-183X
McCaughan, D, Booth, A, Jackson, C et al. (6 more authors) (2019) Orthotic management of instability of the knee related to neuromuscular and central nervous system disorders: qualitative interview study of patient perspectives. BMJ Open, 9 (10). e029313. ISSN 2044-6055
McDaid, C, Fayter, D, Booth, A et al. (9 more authors) (2017) Systematic review of the evidence on orthotic devices for the management of knee instability related to neuromuscular and central nervous system disorders. BMJ Open, 7 (9). e015927.
Comber, A, Dickie, J, Jarvis, C et al. (2 more authors) (2015) Locating bioenergy facilities using a modified GIS-based location-allocation-algorithm: Considering the spatial distribution of resource supply. Applied Energy, 154. pp. 309-316. ISSN 0306-2619
Kay, P, Grayson, R, Phillips, M et al. (7 more authors) (2012) The effectiveness of agricultural stewardship for improving water quality at the catchment scale: Experiences from an NVZ and ECSFDI watershed. Journal of Hydrology, 422-42. 10 - 16 (7). ISSN 0022-1694
Boulton, A, Boyd, P, Cheng, KK et al. (346 more authors) (2000) The United Kingdom Childhood Cancer Study: objectives, materials and methods. British Journal of Cancer, 82 (5). pp. 1073-1102. ISSN 1532-1827
Monograph
O’Connor, J, McCaughan, D, McDaid, C et al. (10 more authors) (2016) Orthotic management of instability of the knee related to neuromuscular and central nervous system disorders: systematic review, qualitative study, survey and costing analysis. Report. NIHR Journals Library , Health Technology Assessment. ISSN 1366-5278
Conference or Workshop Item
Schmid, P, Abraham, J, Chan, S et al. (17 more authors) (2018) AZD5363 plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (PAKT): A randomised, double-blind, placebo-controlled, phase II trial. In: 2018 ASCO Annual Meeting, 01-05 Jun 2018, Chicago, IL, USA.